Proficio Capital Partners LLC Buys Shares of 19,790 The Chemours Company (NYSE:CC)

Proficio Capital Partners LLC purchased a new position in The Chemours Company (NYSE:CCFree Report) during the 4th quarter, HoldingsChannel.com reports. The firm purchased 19,790 shares of the specialty chemicals company’s stock, valued at approximately $334,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. GAMMA Investing LLC lifted its holdings in Chemours by 99.7% during the 4th quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after buying an additional 765 shares in the last quarter. Truvestments Capital LLC bought a new stake in shares of Chemours during the third quarter valued at approximately $35,000. Brooklyn Investment Group purchased a new stake in shares of Chemours in the third quarter valued at approximately $37,000. KBC Group NV grew its stake in Chemours by 38.2% in the fourth quarter. KBC Group NV now owns 6,176 shares of the specialty chemicals company’s stock worth $104,000 after purchasing an additional 1,708 shares in the last quarter. Finally, EMC Capital Management increased its holdings in Chemours by 74.6% during the 4th quarter. EMC Capital Management now owns 9,534 shares of the specialty chemicals company’s stock worth $161,000 after purchasing an additional 4,073 shares during the period. 76.26% of the stock is owned by institutional investors.

Chemours Stock Performance

Shares of CC stock opened at $14.16 on Wednesday. The stock has a market cap of $2.12 billion, a PE ratio of 24.84 and a beta of 2.00. The Chemours Company has a 52-week low of $13.09 and a 52-week high of $29.21. The business has a 50-day simple moving average of $16.72 and a 200-day simple moving average of $18.27. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70.

Chemours (NYSE:CCGet Free Report) last announced its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.37 billion. On average, equities analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 7.06%. The ex-dividend date was Friday, February 28th. Chemours’s payout ratio is 175.44%.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Mizuho dropped their target price on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Barclays decreased their target price on shares of Chemours from $23.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, February 24th. Truist Financial began coverage on Chemours in a research note on Tuesday, January 28th. They issued a “buy” rating and a $27.00 price target for the company. Morgan Stanley cut their price target on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Monday, January 13th. Finally, BMO Capital Markets dropped their price target on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 19th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $23.11.

Check Out Our Latest Report on CC

Chemours Profile

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Articles

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.